ArticleCureus2025
The Predictive Accuracy of Hounsfield Units and Urinary pH in the Non-invasive Diagnosis of Radiolucent Urinary Stones.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Radiolucent urinary calculi, primarily uric acid and struvite stones, pose a diagnostic challenge due to their indistinct appearance on plain radiographs. Differentiating between these two types is essential, as they require markedly different therapeutic strategies. This study evaluates the combined utility of Hounsfield units (HU) from non-contrast computed tomography (NCCT) and urine pH values as non-invasive predictors of stone composition in radiolucent calculi. We hypothesized that the combination of HU and urine pH can accurately differentiate between uric acid and struvite stones. Methods We conducted a retrospective cohort study of 110 adult patients with radiolucent stones confirmed by chemical analysis between January 2021 and December 2024 at Queen Elizabeth Hospital, Birmingham. HU values were measured on NCCT, and urine pH was calculated as the mean from all available urinalysis records over the preceding six months. Infection markers (nitrite and leukocyte esterase) were also recorded. All patients underwent a X-ray kidneys, ureters, and bladder (KUB) to confirm radiolucency. Patients with mixed or radiopaque stones were excluded. Results Of the 110 patients, 65 had uric acid stones and 45 had struvite stones. Uric acid stones exhibited significantly lower HU values (432±98) and more acidic urine (pH: 5.5±0.3) compared to struvite stones (HU: 694±182, pH: 6.7±0.4; p<0.001 for both). Nitrite and leukocyte esterase positivity were also significantly higher in the struvite group (82% and 84%, respectively) than in the uric acid group (24% and 38%; p<0.001). A diagnostic threshold of HU ≤500 and pH ≤5.5 predicted uric acid stones with 87% sensitivity and 83% specificity, while HU >600 and pH >7 predicted struvite stones with 85% accuracy. Receiver operating characteristic (ROC) curve analysis demonstrated an area under the curve (AUC) of 0.94, indicating excellent diagnostic performance. Conclusion HU and urine pH are effective, non-invasive tools for differentiating uric acid from struvite radiolucent stones. Their combined use enables early, targeted medical management and may reduce reliance on delayed surgical confirmation, especially in systems with long elective wait times. Incorporating these parameters into routine clinical triage could significantly improve outcomes in patients with radiolucent urolithiasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.